Researchers at Queen Mary's Barts Cancer Institute have found a more active approach to monitoring and treating people with a ...

The FDA granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare ...

The designation applies to investigational therapies that target rare diseases affecting less than 200,000 people in the US.

Estonia is a hotbed of healthcare technology innovation, harnessing artificial intelligence (AI) and genomics. Its healthtech industry is targeting the UK and Europe for collaboration and market ...

If you are like a lot of people, you might be anxious about the risk of getting dementia as you age. The lifetime risk of ...

New research has shown that the introduction childhood screening for type 1 diabetes is ‘effective’ and would help reduce ...

GSK gets an entry in the list with Exdensur (depemokimab), a twice-yearly injectable IL-5 inhibitor for severe asthma, which ...

The Indomo ClearPen is yet to be approved in the UK, but the founders hope for future availability ...

Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.

High body mass index (BMI) could cause a higher risk of vascular-related dementia (a combination of vascular + unspecified ...

Extra training places will be created in areas with the worst cancer outcomes, including rural and coastal communities ...

Nessa Yip sits down with Dr. Ayla Sela to discuss the possibilities of psychedelic medicine The classic psychedelics – LSD, psilocybin, DMT – are psychoactive compounds known to elicit a repertoire of ...